Terms: = Breast cancer AND TLX3, O43711, 30012, ENSG00000164438, HOX11L2, RNX
2 results:
1. A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients.
Pineda B; Diaz-Lagares A; Pérez-Fidalgo JA; Burgués O; González-Barrallo I; Crujeiras AB; Sandoval J; Esteller M; Lluch A; Eroles P
Clin Epigenetics; 2019 Feb; 11(1):33. PubMed ID: 30786922
[TBL] [Abstract] [Full Text] [Related]
2. The evolutionarily conserved transcription factor PRDM12 controls sensory neuron development and pain perception.
Nagy V; Cole T; Van Campenhout C; Khoung TM; Leung C; Vermeiren S; Novatchkova M; Wenzel D; Cikes D; Polyansky AA; Kozieradzki I; Meixner A; Bellefroid EJ; Neely GG; Penninger JM
Cell Cycle; 2015; 14(12):1799-808. PubMed ID: 25891934
[TBL] [Abstract] [Full Text] [Related]
